Chief Medical Officer Martins Eduardo Bruno sold Sagimet Biosciences Inc. ($SGMT) shares on the open market twice in the last year for a total of $95,118. His most recent sale occurred on February 10, 2026. These insider sales rank 9,660th among 11,678 individuals in our database, where the average is $8.6 million across 6.4 transactions. He made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | Sagimet Biosciences Inc. | $SGMT | Martins Eduardo Bruno | Chief Medical Officer | A | Stock Option (Right to Buy) | 88000 | $0.00 | 88,000.0000 | 32,464,893 | 9999.99% | 0.27% |
| Feb. 19, 2026 | Sagimet Biosciences Inc. | $SGMT | Martins Eduardo Bruno | Chief Medical Officer | A | Series A Common Stock | 44000 | $0.00 | 147,296.0000 | 32,464,893 | 42.60% | 0.14% |
| Feb. 10, 2026 | Sagimet Biosciences Inc. | $SGMT | Martins Eduardo Bruno | Chief Medical Officer | S | Series A Common Stock | 3640 | $5.36 | 103,296.0000 | 32,464,893 | 3.40% | 0.01% |
| July 21, 2025 | Sagimet Biosciences Inc. | $SGMT | Martins Eduardo Bruno | Chief Medical Officer | S | Series A Common Stock | 8277 | $9.13 | 106,936.0000 | 32,195,366 | 7.18% | 0.03% |
| Feb. 6, 2025 | Sagimet Biosciences Inc. | $SGMT | Martins Eduardo Bruno | Chief Medical Officer | A | Series A Common Stock | 34000 | $0.00 | 115,213.0000 | 31,350,725 | 41.87% | 0.11% |
| Feb. 6, 2025 | Sagimet Biosciences Inc. | $SGMT | Martins Eduardo Bruno | Chief Medical Officer | A | Stock Option (Right to Buy) | 138000 | $0.00 | 138,000.0000 | 31,350,725 | 9999.99% | 0.44% |
| July 19, 2024 | Sagimet Biosciences Inc. | $SGMT | Martins Eduardo Bruno | Chief Medical Officer | S | Series A Common Stock | 8357 | $3.10 | 81,213.0000 | 31,913,887 | 9.33% | 0.03% |